MICHAEL CHARLES: Open Payments
NPI 1780292383 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 38 payments from 10 companies in 2025. Trend: 2023 $775 · 2024 $701 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $328 |
| Merck Sharp & Dohme LLC | 8 | $132 |
| Amgen Inc. | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Novo Nordisk Inc | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| PFIZER INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: CAMZYOS, VERQUVO, Repatha, JARDIANCE, LEQVIO, ELIQUIS, CAPVAXIVE, Rybelsus.
Industry payments across AL — which companies pay providers there.
